Mainolfi Nello Insider Trading -- Recent SEC Form 4 Transactions
Mainolfi Nello (CIK 1821189) reported 40 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-10-01). Recent activity: Buy KYMR (30,000 shares), Sell KYMR (3,525 shares), Sell KYMR (5,506 shares), Sell KYMR (4,876 shares), Sell KYMR (7,601 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-01 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Buy | 30,000 | $62,400 |
| 2026-10-01 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 3,525 | $392,826 |
| 2026-10-01 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 5,506 | $618,985 |
| 2026-10-01 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 4,876 | $552,158 |
| 2026-10-01 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 7,601 | $869,782 |
| 2026-10-01 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 8,230 | $949,742 |
| 2026-10-01 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 262 | $30,423 |
| 2026-07-07 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Buy | 50,000 | $104,000 |
| 2026-07-07 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 50,000 | $6.0M |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 24,105 | $2.8M |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 1,883 | $212,411 |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 6,626 | $755,204 |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Buy | 80,000 | $166,400 |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 44,050 | $5.1M |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 3,336 | $388,841 |
| 2026-04-29 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Buy | 30,000 | $62,400 |
| 2026-04-29 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 17,005 | $1.4M |
| 2026-04-29 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 12,059 | $985,220 |
| 2026-04-29 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 936 | $77,173 |
| 2026-02-25 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Buy | 30,000 | $62,400 |
| 2026-02-25 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 19,764 | $1.8M |
| 2026-02-25 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 5,434 | $491,179 |
| 2026-02-25 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 3,293 | $302,166 |
| 2026-02-25 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 1,501 | $139,308 |
| 2026-02-25 | Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer | Sell | 8 | $748 |
Source: SEC Form 4 filings · as of 2026-10-01